关注
Swapnil Talkar
Swapnil Talkar
在 pg.ictmumbai.edu.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Transmucosal nanoparticles: toxicological overview
S Talkar, S Dhoble, A Majumdar, V Patravale
Cellular and molecular toxicology of nanoparticles, 37-57, 2018
272018
Gene therapy for prostate cancer: A review
SS Talkar, VB Patravale
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021
152021
An industrially viable technique for fabrication of docetaxel NLCs for oncotherapy
PB Kharkar, SS Talkar, VB Patravale
International Journal of Pharmaceutics 577, 119082, 2020
122020
A rapid and sensitive bio analytical RP-HPLC method for detection of docetaxel: development and validation
P Kharkar, S Talkar, VB Patravale
Indian J Pharm Educ 51 (4), 729-734, 2017
92017
Nanosystems for oral delivery of immunomodulators, nanostructures for oral medicine
PB Kharkar, SS Talkar, NA Kadwadkar, VB Patravale
Elsevier, 2017
92017
Nanosystems for oral delivery of immunomodulators
PB Kharkar, SS Talkar, NA Kadwadkar, VB Patravale
Nanostructures for Oral Medicine, 295-334, 2017
92017
Docetaxel loaded pomegranate seed oil based nanostructured lipid carriers: a potential alternative to current formulation
SS Talkar, PB Kharkar, VB Patravale
AAPS PharmSciTech 21, 1-11, 2020
82020
Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer Therapy
P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ...
Micro-and Nanotechnologies-Based Product Development, 95-114, 2021
2021
7 Targeted Lipid-Based
P Upadhaya, S Talkar, V Ghodake, N Kadwadkar, A Pandya, S Pulakkat, ...
Micro-and Nanotechnologies-Based Product Development, 95, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–9